These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

231 related items for PubMed ID: 15537475

  • 1. A comparison of the fourth-generation fluoroquinolones gatifloxacin 0.3% and moxifloxacin 0.5% in terms of ocular tolerability.
    Donnenfeld E, Perry HD, Chruscicki DA, Bitterman A, Cohn S, Solomon R.
    Curr Med Res Opin; 2004 Nov; 20(11):1753-8. PubMed ID: 15537475
    [Abstract] [Full Text] [Related]

  • 2. Rate of bacterial eradication by ophthalmic solutions of fourth-generation fluoroquinolones.
    Callegan MC, Novosad BD, Ramadan RT, Wiskur B, Moyer AL.
    Adv Ther; 2009 Apr; 26(4):447-54. PubMed ID: 19381523
    [Abstract] [Full Text] [Related]

  • 3. The effect of fourth-generation fluoroquinolones gatifloxacin and moxifloxacin on epithelial healing following photorefractive keratectomy.
    Burka JM, Bower KS, Vanroekel RC, Stutzman RD, Kuzmowych CP, Howard RS.
    Am J Ophthalmol; 2005 Jul; 140(1):83-7. PubMed ID: 15953577
    [Abstract] [Full Text] [Related]

  • 4. Fourth-generation fluoroquinolone penetration into the aqueous humor in humans.
    McCulley JP, Caudle D, Aronowicz JD, Shine WE.
    Ophthalmology; 2006 Jun; 113(6):955-9. PubMed ID: 16603244
    [Abstract] [Full Text] [Related]

  • 5. Effect of gatifloxacin 0.3% and moxifloxacin 0.5% ophthalmic solutions on human corneal epithelium following 2 dosing regimens.
    Price MO, Price FW, Maclellan D.
    J Cataract Refract Surg; 2005 Nov; 31(11):2137-41. PubMed ID: 16412928
    [Abstract] [Full Text] [Related]

  • 6. Comparison of the effects of fourth-generation fluoroquinolones on epithelial healing after photorefractive keratectomy.
    Shin JH, Lee HB, Park HY.
    Cornea; 2010 Nov; 29(11):1236-40. PubMed ID: 20697276
    [Abstract] [Full Text] [Related]

  • 7. In vitro antifungal activity of the fourth generation fluoroquinolones against Candida isolates from human ocular infections.
    Ozdek SC, Miller D, Flynn PM, Flynn HW.
    Ocul Immunol Inflamm; 2006 Dec; 14(6):347-51. PubMed ID: 17162605
    [Abstract] [Full Text] [Related]

  • 8. Penetration of topically applied gatifloxacin 0.3%, moxifloxacin 0.5%, and ciprofloxacin 0.3% into the aqueous humor.
    Solomon R, Donnenfeld ED, Perry HD, Snyder RW, Nedrud C, Stein J, Bloom A.
    Ophthalmology; 2005 Mar; 112(3):466-9. PubMed ID: 15745775
    [Abstract] [Full Text] [Related]

  • 9. Antimicrobial efficacy of prophylactic gatifloxacin 0.3% and moxifloxacin 0.5% in patients undergoing phacoemulsification surgery.
    Bucci FA, Amico LM, Evans RE.
    Eye Contact Lens; 2008 Jan; 34(1):39-42. PubMed ID: 18180682
    [Abstract] [Full Text] [Related]

  • 10. Confocal assessment of the effects of fourth-generation fluoroquinolones on the cornea.
    Ly LT, Cavanagh HD, Petroll WM.
    Eye Contact Lens; 2006 Jul; 32(4):161-5. PubMed ID: 16845259
    [Abstract] [Full Text] [Related]

  • 11. Safety of prophylactic intracameral moxifloxacin 0.5% ophthalmic solution in cataract surgery patients.
    Espiritu CR, Caparas VL, Bolinao JG.
    J Cataract Refract Surg; 2007 Jan; 33(1):63-8. PubMed ID: 17189795
    [Abstract] [Full Text] [Related]

  • 12. Aqueous penetration and biological activity of moxifloxacin 0.5% ophthalmic solution and gatifloxacin 0.3% solution in cataract surgery patients.
    Kim DH, Stark WJ, O'Brien TP, Dick JD.
    Ophthalmology; 2005 Nov; 112(11):1992-6. PubMed ID: 16183125
    [Abstract] [Full Text] [Related]

  • 13. Aqueous humor penetration of gatifloxacin and moxifloxacin eyedrops given by different methods before cataract surgery.
    Ong-Tone L.
    J Cataract Refract Surg; 2007 Jan; 33(1):59-62. PubMed ID: 17189794
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Corneal wound healing in New Zealand White Rabbits following anterior keratectomy and treatment with moxifloxacin ophthalmic solution 0.5% or gatifloxacin ophthalmic solution 0.3%.
    Williams KK, Shepard AR, Rice RL, McCartney MD, Wax MB, Hiddemen JW.
    J Ocul Pharmacol Ther; 2007 Dec; 23(6):517-25. PubMed ID: 18001231
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Ocular pharmacokinetics/pharmacodynamics of besifloxacin, moxifloxacin, and gatifloxacin following topical administration to pigmented rabbits.
    Proksch JW, Ward KW.
    J Ocul Pharmacol Ther; 2010 Oct; 26(5):449-58. PubMed ID: 20874668
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Aqueous humor penetration of gatifloxacin and moxifloxacin eyedrops given in different concentrations in a wick before cataract surgery.
    Ong-Tone L.
    J Cataract Refract Surg; 2008 May; 34(5):819-22. PubMed ID: 18471639
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.